Core Viewpoint - Azenta reported mixed financial results for fiscal Q1 2026, with a slight revenue increase but organic revenue decline, reflecting ongoing macroeconomic challenges and cautious capital spending [2][3]. Financial Performance - Fiscal Q1 2026 revenue was $149 million, up 1% reported but down 1% organically [2]. - Non-GAAP EPS was $0.09, and adjusted EBITDA margin was 8.5%, down approximately 230 basis points year over year [4]. - Gross margin for the quarter was 44.1%, a decline of 360 basis points from the previous year [5]. Management Commentary - CEO John Marotta noted that organic revenue decline was expected due to uneven market conditions and weak capital spending, particularly affected by government funding uncertainties [3]. - CFO Lawrence Lin indicated that foreign exchange posed a 2% headwind to results and attributed profitability pressure to lower gross margins and underutilized lab capacity [4]. Segment Performance - In Sample Management Solutions (SMS), revenue was $81 million, flat reported and down 2% organically, with growth in biorepositories offset by declines in Automated Stores and Cryo [6]. - SMS gross margin was 45.4%, down 370 basis points year over year, primarily due to higher rework costs on Automated Stores projects [7]. Future Outlook - Management reaffirmed full-year guidance for 3% to 5% organic revenue growth and approximately 300 basis points of adjusted EBITDA margin expansion, acknowledging that growth and profitability improvements are expected to be more pronounced in the second half of the year [2].